Skip to main content

Oligonucleotide GMP Manufacturing

Accelerate Oligos from Clinic to Market

必威体育登录手机Partnering with Agilent, an experienced contract development and manufacturing organization, will give you the confidence that your clinical and commercial oligonucleotide API will meet appropriate specifications, quality, and purity requirements.

必威体育登录手机In two state-of-the art cGMP facilities in Colorado, U.S., Agilent produces grams to kilograms of siRNA, antisense, aptamers, sgRNA, and other oligos.We are expanding capacity to take on more programs, increase batch sizes, and address our partners' needs more quickly.

必威体育登录手机Agilent supports several commercial programs, so you can rely on our expertise throughout clinical trials and commercialization.Accelerate speed to clinic and market, scale chemical processes, and produce high-quality oligo API with us.
Contact Us
+1 866-744-7638

Refine By

必威体育赛事投注

|
|

Sort Alphabetically

Filter by
Filter Content Selection Tool

Need Help?必威体育赛事投注Find products using our Selection Tool.

Featured Videos
Return to top
Featured News

必威体育登录手机Agilent to Acquire North American CDMO BIOVECTRA

必威体育登录手机Agilent Technologies signed a definitive agreement to acquire BIOVECTRA, a leading specialized contract development and manufacturing organization, for $925 million.Based in Canada, BIOVECTRA produces biologics, highly potent active pharmaceutical ingredients, and other molecules for targeted therapeutics.必威体育登录手机This expands Agilent's end-to-end biopharma solutions that accelerate drug discovery, development, and manufacturing.

0 product selected.

Clear All


Baidu
map